Biomarkers · Chemical
A plain-language description with its source has not been added for this biomarker yet. What the laboratories say about the tests that measure it is below.
What the laboratory says this test is for
This panel evaluates for the most common hereditary and acquired venous thrombophilia risk factors.
Quest Diagnostics test directory, test code 19656
Quest Diagnostics test directory, test code 19671
What the laboratory says this test is for
Aids in the detection of hypercoagulable states associated with venous thrombotic episodes. May be useful in patients who appear to be hyporesponsive to heparin.
Quest Diagnostics test directory, test code 216
What the laboratory says this test is for
Factor V Leiden (R506Q) is the most common genetic determinant for hereditary venous thrombosis. Another DNA variant, the HR2 allele, has been associated with a 3-4 fold increased risk to venous thrombosis when it occurs in the presence of the Factor V Leiden mutation.
Quest Diagnostics test directory, test code 11327
What the laboratory says this test is for
This panel is useful to determine the etiology of various hypercoagulability states.
Quest Diagnostics test directory, test code 11051
What the laboratory says this test is for
Aids in characterization of Antithrombin deficiency (AT, previously referred to as Antithrombin III) which is associated with increased thrombotic risk. Type I deficiency is characterized by reduction in activity and antigen levels simultaneously. With type II deficiency, activity levels are lower in comparison to the antigen levels (dysfunctional protein). Acquired deficiency, more common than inherited defects, can occur due to: liver disease, nephrotic syndrome, heparin therapy, disseminated intra- vascular coagulation (DIC), sepsis, and L-asparaginase chemotherapy.Anticoagulant Interference: Expected impact by therapeutic levels (potential interference depends upon drug concentration): Warfarin: no effect; Heparin (UFH or LMWH): no effect to decrease (UFH may decrease levels physiologically but no assay interference); Dabigatran or Argatroban (Thrombin Inhibitors): may falsely increase activity levels; Rivaroxaban, Apixaban, Edoxaban (Factor Xa Inhibitors): no effect.
Quest Diagnostics test directory, test code 8267
What the laboratory says this test is for
This panel evaluates for the most common hereditary and acquired venous thrombophilia risk factors except for Protein C and S.
Quest Diagnostics test directory, test code 19655
What the laboratory says this test is for
This profile examines the most common hereditary and acquired thrombophilia risk factors associated with recurrent miscarriage or stillbirth.
Quest Diagnostics test directory, test code 11469
What the laboratory says this test is for
This panel evaluates for the most common hereditary and acquired venous thrombophilia risk factors.
Quest Diagnostics test directory, test code 11475
What the laboratory says this test is for
This panel evaluates for the most common hereditary and acquired venous thrombophilia risk factors except for Protein C and S.
Quest Diagnostics test directory, test code 11472
Everything above is drawn from the named sources and shown as they published it. Reference ranges belong to the laboratory that issued them and the population it named; they are not a universal normal. This page describes the biomarker in general and does not interpret anyone's result. For your own numbers, talk to a clinician, or use Aumnivida, which reads the same graph next to your records.
Found an error? Write to hello@biomarkerlens.com with the page link and the source that contradicts it.